Home Krystal Biotech

Krystal Biotech

In operation
Post-IPO Round
Gene Therapy Developer
Basic
Enterprise Profile

Basic Information

Krystal Biotech, Inc. is a clinical-stage gene therapy company developing effective and innovative treatments for skin diseases using its proprietary Skin TARgeted Delivery (STAR-D) platform. While the company is initially focused on developing topical and intradermal “off-the-shelf” new therapies for rare and orphan dermatological indications, it is expanding the use of its groundbreaking STAR-D technology to target and treat other skin conditions.
Krystal Biotech, Inc.
Pittsburgh,Pennsylvania,United States of America
101~500 people
January 01, 2015
inquiries@krystalbio.com

Enterprise Profile

Industrial Sector
New Drug Development Gene Therapy Production of Genetically Engineered Drugs
Technology
Gene Technology Biotechnology
Concept
Dermatology Department Rare Diseases Therapeutic Products
Application Scenarios
Innovative Drugs Cell and Gene Therapy